Strengthening a workforce for innovative regulatory science in therapeutics development workshop summary /

Public health effectiveness of the FDA 510(k) clearance process balancing patient safety and innovation : workshop report /
Vydáno: (2010)

Assuring data quality and validity in clinical trials for regulatory decision making workshop report : Roundtable on Research and Development of Drugs, Biologics, and Medical Devices /
Vydáno: (1999)

Development and approval of combination products a regulatory perspective /
Vydáno: (2008)

Reputation and power organizational image and pharmaceutical regulation at the FDA
Autor: Carpenter, Daniel P., 1967-
Vydáno: (2010)

Public health effectiveness of the FDA 510(k) clearance process balancing patient safety and innovation : workshop report /
Vydáno: (2011)

Evaluation of certain veterinary drug residues in food sixty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives.
Vydáno: (2006)

The future of drug safety promoting and protecting the health of the public /
Vydáno: (2007)

Accelerating the development of biomarkers for drug safety workshop summary /
Vydáno: (2009)

Development of FDA-regulated medical products : a translational approach /
Autor: Whitmore, Elaine
Vydáno: (2012)

Establishing precompetitive collaborations to stimulate genomics-driven product development workshop summary /
Vydáno: (2011)

Therapeutic justice and addicted parents a family treatment court evaluation /
Autor: McMillin, Heidee, 1964-
Vydáno: (2012)

Risk-characterization framework for decision-making at the food and drug administration
Vydáno: (2011)

Allied health workforce and services workshop summary /
Vydáno: (2011)

Therapeutic delivery solutions /
Vydáno: (2014)

The risks of prescription drugs
Vydáno: (2010)

Adverse drug event reporting the roles of consumers and health-care professionals : workshop summary /
Vydáno: (2007)

Rational therapeutics for infants and children workshop summary /
Vydáno: (2000)

Enhancing food safety the role of the Food and Drug Administration /
Vydáno: (2010)

Understanding the benefits and risks of pharmaceuticals workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy /
Vydáno: (2007)

Residue evaluation of certain veterinary drugs : Joint FAO/WHO Expert Committee on Food Additives, 75th meeting, Rome, Italy, 8-17 November 2011.
Vydáno: (2012)

Acceptable risks politics, policy, and risky technologies /
Autor: Heimann, C. F. Larry (Clarence Fredrick)
Vydáno: (1997)

Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Vydáno: (2008)

Food labelling the FDA's role in the selection of healthy foods /
Vydáno: (2009)

Building a resilient workforce opportunities for the Department of Homeland Security, workshop summary /
Vydáno: (2012)

Development of therapeutic agents handbook
Vydáno: (2012)

Drug trade, trafficking and policies
Vydáno: (2011)

Enhancing the regulatory decision-making approval process for direct food ingredient technologies workshop summary /
Vydáno: (1999)

Toxicological evaluation of certain veterinary drug residues in food
Vydáno: (2009)

WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
Vydáno: (2005)

WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
Vydáno: (2006)

WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
Vydáno: (2007)

Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
Vydáno: (2009)

Understanding the demand for illegal drugs
Vydáno: (2010)

Absorption and drug development solubility, permeability, and charge state /
Autor: Avdeef, Alex
Vydáno: (2012)

Drug-drug interactions in pharmaceutical development
Vydáno: (2008)

European studies on drugs and drug policy : selected readings from the 14th International Conference of the European Society for Social Drug Research (ESSD) /
Vydáno: (2004)